Market Research Logo

MedImmune, LLC - Product Pipeline Review - 2016

MedImmune, LLC - Product Pipeline Review - 2016

Summary


Global Markets Direct’s, ‘MedImmune, LLC - Product Pipeline Review - 2016’, provides an overview of the MedImmune, LLC’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by MedImmune, LLC, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of MedImmune, LLC
  • The report provides overview of MedImmune, LLC including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses MedImmune, LLC’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features MedImmune, LLC’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate MedImmune, LLC’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for MedImmune, LLC
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding MedImmune, LLC’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


MedImmune, LLC Snapshot
MedImmune, LLC Overview
Key Information
Key Facts
MedImmune, LLC - Research and Development Overview
Key Therapeutic Areas
MedImmune, LLC - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Pipeline Products - Out-Licensed Products
MedImmune, LLC - Pipeline Products Glance
MedImmune, LLC - Late Stage Pipeline Products
MedImmune, LLC - Clinical Stage Pipeline Products
MedImmune, LLC - Early Stage Pipeline Products
MedImmune, LLC - Drug Profiles
MEDI-550
anifrolumab
benralizumab
durvalumab
durvalumab + tremelimumab
influenza [strains A/H1N1 + A/H3N2 + B/Yamagata + B/Victoria] (quadrivalent) vaccine
moxetumomab pasudotox
tralokinumab
inebilizumab
dusigitumab
INO-3112
mavrilimumab
MEDI-2070
MEDI-3902
MEDI-4893
MEDI-6012
MEDI-7510
MEDI-8852
MEDI-8897
tremelimumab
inebilizumab + MEDI-0680
MEDI-0382
AMG-211
AMP-110
AMP-224
durvalumab + gefitinib
durvalumab + MEDI-0680
durvalumab + MEDI-6383
inebilizumab + rituximab
MEDI-0562
MEDI-0639
MEDI-0680
MEDI-1814
MEDI-1873
MEDI-3617
MEDI-3617 + tremelimumab
MEDI-4166
MEDI-4276
MEDI-4920
MEDI-6383
MEDI-7836
MEDI-8111
MEDI-9197
MEDI-9447
Oncolytic Virus to Activate IFN-b for Hepatocellular Carcinoma and Head And Neck Cancer Squamous Cell Carcinoma
respiratory syncytial virus vaccine 1
respiratory syncytial virus vaccine 2
MEDI-5117
264-RAD
Biologics for Acute Coronary Syndrome
EVT-770
MEDI-5304
MEDI-9314
Monoclonal Antibody Conjugates to Inhibit DNA Synthesis for Solid and Hematological Tumors
Monoclonal Antibody to Inhibit ILT7 for Systemic Lupus Erythematosus
PRO-391
V-2L2MD
ALM
Monoclonal Antibodies for Cancer
Monoclonal Antibody to Antagonize ECA for Enterobacteriaceae Infections
Recombinant Proteins for Cancer
MedImmune, LLC - Pipeline Analysis
MedImmune, LLC - Pipeline Products by Target
MedImmune, LLC - Pipeline Products by Route of Administration
MedImmune, LLC - Pipeline Products by Molecule Type
MedImmune, LLC - Pipeline Products by Mechanism of Action
MedImmune, LLC - Recent Pipeline Updates
MedImmune, LLC - Dormant Projects
MedImmune, LLC - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
MedImmune, LLC - Company Statement
MedImmune, LLC - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
MedImmune, LLC - Key Manufacturing Facilities
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
MedImmune, LLC, Key Information
MedImmune, LLC, Key Facts
MedImmune, LLC - Pipeline by Indication, 2016
MedImmune, LLC - Pipeline by Stage of Development, 2016
MedImmune, LLC - Monotherapy Products in Pipeline, 2016
MedImmune, LLC - Combination Treatment Modalities in Pipeline, 2016
MedImmune, LLC - Partnered Products in Pipeline, 2016
MedImmune, LLC - Partnered Products/ Combination Treatment Modalities, 2016
MedImmune, LLC - Out-Licensed Products in Pipeline, 2016
MedImmune, LLC - Out-Licensed Products/ Combination Treatment Modalities, 2016
MedImmune, LLC - Pre-Registration, 2016
MedImmune, LLC - Phase III, 2016
MedImmune, LLC - Phase II, 2016
MedImmune, LLC - Phase I, 2016
MedImmune, LLC - Phase 0, 2016
MedImmune, LLC - IND/CTA Filed, 2016
MedImmune, LLC - Preclinical, 2016
MedImmune, LLC - Discovery, 2016
MedImmune, LLC - Pipeline by Target, 2016
MedImmune, LLC - Pipeline by Route of Administration, 2016
MedImmune, LLC - Pipeline by Molecule Type, 2016
MedImmune, LLC - Pipeline Products by Mechanism of Action, 2016
MedImmune, LLC - Recent Pipeline Updates, 2016
MedImmune, LLC - Dormant Developmental Projects,2016
MedImmune, LLC - Discontinued Pipeline Products, 2016
MedImmune, LLC, Other Locations
MedImmune, LLC, Subsidiaries
MedImmune, LLC, Key Manufacturing Facilities
List of Figures
MedImmune, LLC - Pipeline by Top 10 Indication, 2016
MedImmune, LLC - Pipeline by Stage of Development, 2016
MedImmune, LLC - Monotherapy Products in Pipeline, 2016
MedImmune, LLC - Combination Treatment Modalities in Pipeline, 2016
MedImmune, LLC - Partnered Products in Pipeline, 2016
MedImmune, LLC - Out-Licensed Products in Pipeline, 2016
MedImmune, LLC - Pipeline by Target, 2016
MedImmune, LLC - Pipeline by Route of Administration, 2016
MedImmune, LLC - Pipeline by Top 10 Molecule Type, 2016
MedImmune, LLC - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report